Literature DB >> 14711720

Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome.

Robert Ritch1, Clement C Y Tham, Dennis S C Lam.   

Abstract

OBJECTIVE: To document the long-term effect of argon laser peripheral iridoplasty (ALPI) in eyes with plateau iris syndrome.
DESIGN: Retrospective, noncomparative, interventional case series.
SETTING: New York Eye and Ear Infirmary.
METHODS: The charts of all patients with plateau iris syndrome treated with ALPI from 1982 to 1991 and subsequently followed for 6 or more years were retrospectively reviewed. Patients with lens-related mechanisms contributing to angle closure (e.g., phacomorphic or malignant glaucoma) were excluded. MAIN OUTCOME MEASURES: Necessity for repeat ALPI and/or any additional means of intervention.
RESULTS: A total of 26 ALPI procedures were performed in 23 eyes of 14 patients (4 men, 10 women). The mean age was 61+/-8.7 years. The mean follow-up was 78.9+/-8.0 months (range, 72-188 months). The angle in 20 of 23 (87.0%) eyes remained open throughout the entire follow-up period after only 1 treatment with ALPI. In 3 eyes, there was gradual reclosure of the angle 5 to 9 years after initial ALPI, but they were readily reopened and maintained open by a single repeat treatment. No filtration surgery was necessary in any eye during follow-up.
CONCLUSIONS: ALPI is highly effective in eliminating residual appositional closure after laser iridotomy caused by plateau iris syndrome. The effect is maintained for years, although a small proportion of patients might require retreatment.

Entities:  

Mesh:

Year:  2004        PMID: 14711720     DOI: 10.1016/j.ophtha.2003.05.001

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  31 in total

1.  Lens extraction in primary angle closure.

Authors:  W Nolan
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Evaluation of the efficacy of laser peripheral iridoplasty in reversing the darkroom provocative test result in Chinese patients with primary angle closure status post laser iridotomy.

Authors:  Ping Huang; Ling-Ling Wu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

3.  Urrets-Zavalia syndrome as a complication of argon laser peripheral iridoplasty.

Authors:  E M Espana; A Ioannidis; C Tello; J M Liebmann; P Foster; R Ritch
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

Review 4.  Laser peripheral iridoplasty for angle-closure.

Authors:  Wai Siene Ng; Ghee Soon Ang; Augusto Azuara-Blanco
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 5.  Lasers in Glaucoma: an Overview.

Authors:  Bhawesh Chandra Saha; Rashmi Kumari; Bibhuti Prasanna Sinha; Anita Ambasta; Sanjeev Kumar
Journal:  Int Ophthalmol       Date:  2020-11-19       Impact factor: 2.031

6.  Argon laser peripheral iridoplasty for plateau iris associated with iridociliary cysts: a case report.

Authors:  Ghee Soon Ang; Frank Bochmann; Augusto Azuara-Blanco
Journal:  Cases J       Date:  2008-12-02

7.  PLATEAU IRIS SYNDROME--CASE SERIES.

Authors:  Crenguta Ioana Feraru; Anca Delia Pantalon; Dorin Chiselita; Daniel Branisteanu
Journal:  Rom J Ophthalmol       Date:  2015 Jul-Sep

8.  Learning ECOC Code Matrix for Multiclass Classification with Application to Glaucoma Diagnosis.

Authors:  Xiaolong Bai; Swamidoss Issac Niwas; Weisi Lin; Bing-Feng Ju; Chee Keong Kwoh; Lipo Wang; Chelvin C Sng; Maria C Aquino; Paul T K Chew
Journal:  J Med Syst       Date:  2016-01-21       Impact factor: 4.460

9.  Long-term Outcome of Argon Laser Peripheral Iridoplasty in the Management of Plateau Iris Syndrome Eyes.

Authors:  Jeffrey R Peterson; John W Anderson; Lauren S Blieden; Alice Z Chuang; Robert M Feldman; Nicholas P Bell
Journal:  J Glaucoma       Date:  2017-09       Impact factor: 2.503

10.  Real-world Surgical Outcomes of Primary Angle-closure Glaucoma.

Authors:  Boonsong Wanichwecharungruang; Chompunoot Phumratprapin; Kittipong Kongsomboon; Kasem Seresirikachorn
Journal:  Clin Ophthalmol       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.